National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

paliferminPatient Information
A recombinant form of the endogenous human keratinocyte growth factor. Palifermin binds to epithelial cell surface receptors in the lining of the mouth and gastrointestinal tract, resulting in stimulation of epithelial cell proliferation, differentiation and upregulation of cytoprotective mechanisms. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:growth factor, recombinant human keratinocyte
keratinocyte growth factor, recombinant human
recombinant human keratinocyte growth factor
rhu keratinocyte growth factor
US brand name:Kepivance
Abbreviation:rhKGF



Previous:paclitaxel poliglumex, paclitaxel vitamin E-based emulsion formulation, paclitaxel-loaded polymeric micelle, PADRE 965.10, Palestrol
Next:palifosfamide, Pallace, palladium Pd 103, palladium-bacteriopheophorbide, palonosetron hydrochloride

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov